Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,779
datasets available to search
ShareScore release 0.9.0
Dataset results
1,779 results for “Hodgkin lymphoma”
Phase II Randomized Trial Comparing GA101 and Rituximab in Untreated Low Tumor Burden Indolent Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT01889797. IPD Sharing: NO. Countries: 1. Publications: 4.
Combination Chemotherapy, Rituximab, and Ixazomib Citrate in Treating Patients With Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT02481310. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Brentuximab Vedotin Plus AD in Non-bulky Limited Stage Hodgkin Lymphoma
ClinicalTrials.gov study NCT02505269. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Ulixertinib in Treating Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial)
ClinicalTrials.gov study NCT03698994. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Rituximab in Treating Patients With Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00003820. IPD Sharing: NO. Countries: 1. Publications: 1.
Safety and Efficacy of Idelalisib in Relapsed or Refractory Hodgkin Lymphoma
ClinicalTrials.gov study NCT01393106. IPD Sharing: YES. Countries: 1. Publications: 1.
A Phase II Study of Single-Agent Lenalidomide in Subjects With Relapsed Or Refractory T-Cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00655668. IPD Sharing: Not stated. Countries: 4. Publications: 1.
Brentuximab Vedotin and Combination Chemotherapy in Treating Older Patients With Previously Untreated Stage II-IV Hodgkin Lymphoma
ClinicalTrials.gov study NCT01476410. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Safety and Efficacy Study of CC-90011 in Participants With Relapsed and/or Refractory Solid Tumors and Non-Hodgkin's Lymphomas
ClinicalTrials.gov study NCT02875223. IPD Sharing: Not stated. Countries: 5. Publications: 2.
Avelumab In Patients With Previously Treated Advanced Stage Classical Hodgkin's Lymphoma (JAVELIN HODGKINS)
ClinicalTrials.gov study NCT02603419. IPD Sharing: NO. Countries: 3. Publications: 1.
Study of Bendamustine Hydrochloride and Rituximab (BR) Compared With R-CVP or R-CHOP in the First-Line Treatment of Patients With Advanced Indolent Non-Hodgkin's Lymphoma (NHL) or Mantle Cell Lymphoma
ClinicalTrials.gov study NCT00877006. IPD Sharing: Not stated. Countries: 7. Publications: 3.
JCAR014 and Durvalumab in Treating Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT02706405. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Phase 3 Study of Brentuximab Vedotin (SGN-35) in Patients at High Risk of Residual Hodgkin Lymphoma Following Stem Cell Transplant (The AETHERA Trial)
ClinicalTrials.gov study NCT01100502. IPD Sharing: Not stated. Countries: 13. Publications: 2.
Prospective Observational Study of Febrile Neutropenia (FN) and Pegfilgrastim Primary Prophylaxis in Breast Cancer and Non-Hodgkin's Lymphoma Patients Receiving High (>20%) FN-risk Chemotherapy
ClinicalTrials.gov study NCT02178475. IPD Sharing: Not stated. Countries: 9. Publications: 1.
Ibrutinib in Treating Patients With Relapsed or Refractory Classical Hodgkin Lymphoma
ClinicalTrials.gov study NCT02824029. IPD Sharing: Not stated. Countries: 1. Publications: 1.
S0410 Tandem Stem Cell Transplantation in Treating Patients With Progressive or Recurrent Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00233987. IPD Sharing: Not stated. Countries: 1. Publications: 1.
CAT-8015 in Children, Adolescents and Young Adults With Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00659425. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Chemotherapy, Total-Body Irradiation, Rituximab, and Donor Stem Cell Transplant in Treating Patients With B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00425802. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Phase II Trial of Panobinostat and Lenalidomide in Patients With Relapsed or Refractory Hodgkin's Lymphoma
ClinicalTrials.gov study NCT01460940. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Fludarabine and Rituximab for the Treatment of Marginal Zone Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00117156. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.